Zobrazeno 1 - 10
of 52
pro vyhledávání: '"M. Gerretsen"'
Publikováno v:
European Journal of Emergency Medicine, 28(3), 167-168. Lippincott Williams & Wilkins
Publikováno v:
European Journal of Emergency Medicine, 27(6), 398-399. LIPPINCOTT WILLIAMS & WILKINS
European Journal of Emergency Medicine, 27(6), 398-399. Lippincott Williams & Wilkins
European Journal of Emergency Medicine, 27(6), 398-399. Lippincott Williams & Wilkins
Autor:
Gerard W. M. Visser, Marijke van Walsum, G. B. Snow, M. Gerretsen, Ruud H. Brakenhoff, Guus van Dongen
Publikováno v:
Cell Biophysics, 24-25(1-3), 135-142. Humana Press
Gerretsen, M, Visser, G W M, Brakenhoff, R H, van Walsum, M, Snow, G B & van Dongen, G A M S 1994, ' Complete ablation of small squamous cell carcinoma xenografts with186Re-labeled monoclonal antibody E48 ', Cell Biophysics, vol. 24-25, no. 1-3, pp. 135-142 . https://doi.org/10.1007/BF02789224
Gerretsen, M, Visser, G W M, Brakenhoff, R H, van Walsum, M, Snow, G B & van Dongen, G A M S 1994, ' Complete ablation of small squamous cell carcinoma xenografts with186Re-labeled monoclonal antibody E48 ', Cell Biophysics, vol. 24-25, no. 1-3, pp. 135-142 . https://doi.org/10.1007/BF02789224
In previous studies we have shown that in mice bearing head and neck squamous cell carcinoma (HNSCC) xenografts, radioimmunotherapy (RIT) with186Re-labeled MAb E48 resulted in complete regressions in one-third of the tumors (followup >150 d). MAb E48
Publikováno v:
Oncology reports. 1(1)
There is an urgent need for an effective adjuvant systemic therapy for the treatment of patients with advanced head and neck cancer. This study shows that therapy based on the use of monoclonal antibodies (MAbs) is developing to a realistic option. A
Autor:
B. J. M. Braakhuis, M. Gerretsen, Ad H. G. J. Schrijvers, C. J. L. M. Meijer, M. van Walsum, G. B. Snow, G.A.M.S. (Guus) van Dongen, Jasper J. Quak
Publikováno v:
Gerretsen, M, Schrijvers, A H G J, Van Walsum, M, Braakhuis, B J M, Quak, J J, Meijer, C, Snow, G B & Van Dongen, G A M S 1992, ' Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131 i-labelled monoclonal antibody e48 igg ', British Journal of Cancer, vol. 66, no. 3, pp. 496-502 . https://doi.org/10.1038/bjc.1992.302
British Journal of Cancer
British Journal of Cancer, 66(3), 496-502. Nature Publishing Group
British Journal of Cancer
British Journal of Cancer, 66(3), 496-502. Nature Publishing Group
Monoclonal antibody (MAb) E48 reacts with a 22 kD antigen exclusively expressed in squamous and transitional epithelia and their neoplastic counterparts. Radiolabelled with99mTc, MAb E48 is capable of targeting metastatic and recurrent disease in pat
Autor:
B. J. M. Braakhuis, M. van Walsum, G. B. Snow, G.A.M.S. (Guus) van Dongen, Ad H. G. J. Schrijvers, M. Gerretsen, Jasper J. Quak
Publikováno v:
Cancer Immunology Immunotherapy, 34(4), 252-258. Springer Science and Business Media Deutschland GmbH
Schrijvers, A H G J, Gerretsen, M, van Walsum, M, Braakhuis, B J M, Quak, J J, Snow, G B & van Dongen, G A M S 1992, ' Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984 ', Cancer Immunology Immunotherapy, vol. 34, no. 4, pp. 252-258 . https://doi.org/10.1007/BF01741793
Schrijvers, A H G J, Gerretsen, M, van Walsum, M, Braakhuis, B J M, Quak, J J, Snow, G B & van Dongen, G A M S 1992, ' Potential for targeting head and neck squamous cell carcinoma with monoclonal antibody K984 ', Cancer Immunology Immunotherapy, vol. 34, no. 4, pp. 252-258 . https://doi.org/10.1007/BF01741793
In previous reports we have described the development of mAb K984, reactive with an epitope expressed on the outer cell surface of undifferentiated, proliferating cells in normal stratified squamous epithelia and their neoplastic counterparts [28, 30
Detection of Squamous Cell Carcinoma Xenografts in Nude Mice by Radiolabeled Monoclonal Antibody E48
Autor:
M. Gerretsen, Jasper J. Quak, Gordan B. Snow, Chris J.L.M. Meijer, Guus A.M.S. van Dongen, Ad H. G. J. Schrijvers
Publikováno v:
Quak, J J, Gerretsen, M, Schrijvers, A H G J, Meijer, C J L M, Van Dongen, G A M S & Snow, G B 1991, ' Detection of Squamous Cell Carcinoma Xenografts in Nude Mice by Radiolabeled Monoclonal Antibody E48 ', Archives of Otolaryngology--Head and Neck Surgery, vol. 117, no. 11, pp. 1287-1291 . https://doi.org/10.1001/archotol.1991.01870230103017
Archives of Otolaryngology--Head and Neck Surgery, 117(11), 1287-1291. American Medical Association
Archives of Otolaryngology--Head and Neck Surgery, 117(11), 1287-1291. American Medical Association
We recently produced the monoclonal antibody E48 as a specific reagent for squamous cell carcinomas. In our ongoing investigations to use E48 for clinical tumor detection and therapy, fundamental aspects of the antigen have to be elucidated and pract
Autor:
Jan M. Fritz, M. Gerretsen, Jasper J. Quak, Gordon B. Snow, Marijke van Walsum, Guus A.M.S. van Dongen, Ad H. G. J. Schrijvers
Publikováno v:
Schrijvers, A H G J, Gerretsen, M, Fritz, J M, van Walsum, M, Quak, J J, Snow, G B & van Dongen, G A M S 1991, ' Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma ', Experimental Cell Research, vol. 196, no. 2, pp. 264-269 . https://doi.org/10.1016/0014-4827(91)90260-2
Experimental Cell Research, 196(2), 264-269. Academic Press Inc.
Experimental Cell Research, 196(2), 264-269. Academic Press Inc.
Monoclonal antibody (MAb) E48 recognizes a 20- to 22-kDa antigen expressed by human squamous and transitional epithelia and their neoplastic counterparts. Histochemical examination of these tissues revealed distinct surface labeling with MAb E48 [1].
Autor:
M. Gerretsen, Jasper J. Quak, C. J. L. M. Meijer, J. S. Suh, G.A.M.S. (Guus) van Dongen, G. B. Snow, M. Van Walsum
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 63(1), 37-44. Nature Publishing Group
Gerretsen, M, Quak, J J, Suh, J S, Van Walsum, M, Meijer, C J L M, Snow, G B & Van Dongen, G A M S 1991, ' Superior localisation and imaging of radiolabelled monoclonal antibody e48 f(ab') 2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody e48 igg ', British Journal of Cancer, vol. 63, no. 1, pp. 37-44 . https://doi.org/10.1038/bjc.1991.9
British Journal of Cancer, 63(1), 37-44. Nature Publishing Group
Gerretsen, M, Quak, J J, Suh, J S, Van Walsum, M, Meijer, C J L M, Snow, G B & Van Dongen, G A M S 1991, ' Superior localisation and imaging of radiolabelled monoclonal antibody e48 f(ab') 2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody e48 igg ', British Journal of Cancer, vol. 63, no. 1, pp. 37-44 . https://doi.org/10.1038/bjc.1991.9
Monoclonal antibody (MAb) E48 and its F(ab')2 fragment, radiolabelled with1311, were tested for tumour localisation and imaging in nude mice bearing a squamous cell carcinoma xenograft line derived from a head and neck carcinoma (HNX-HN) or from a vu
Publikováno v:
European journal of gastroenterologyhepatology. 8(11)
To compare the efficacy and safety of lansoprazole 30 mg daily (LAN30) and omeprazole 40 mg daily (OME40) in the treatment of moderate (Savary-Miller grade II) as well as severe reflux oesophagitis (grade III/IVa).A double-blind, randomized, multicen